Skip to contentC
China Pharma Holdings, Inc.
C
CPHIChina Pharma Holdings, Inc. Q2 2015 · 10-Q
Revenue$5.67M$5.67M−7.4% vs Q2 2014 Net Income$1.13M$1.13MN/M vs Q2 2014 EPS Diluted$0.03$0.03N/M vs Q2 2014 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
China Pharma Holdings, Inc. · CIK 1106644 · Engraved from SEC EDGAR
Operating Cash Flowderived-$513,472N/M Free Cash Flowderived-$513,472N/M Margins · derivedGross margin-1.0%−40.4 pt vs Q2 2014
Operating margin-67.0%+72.1 pt vs Q2 2014
Net margin19.9%+160.8 pt vs Q2 2014
ended Jun 30, 2015 · filed Aug 14, 2015 · 45 d after period end